Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 5,500 | $11K |
45 Form 4 filings on record, the earliest from Nov 15, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Ting-Chuan Lee - Director | Open-market sale | Common Stock | 2,894 | $2.55 | $1K | |
| Chun-Jung Tsai - Director | Open-market sale | Common Stock | 7,000 | $2.51 | $4K | |
| Chun-Jung Tsai - Director | Open-market sale | Common Stock | 10,000 | $2.51 | $5K | |
| Chun-Jung Tsai - Director | Open-market sale | Common Stock | 5,000 | $2.61 | $3K | |
| Chun-Jung Tsai - Director | Open-market sale | Common Stock | 10,903 | $2.76 | $6K | |
| Chun-Jung Tsai - Director | Open-market sale | Common Stock | 10,000 | $2.50 | $5K | |
| ASE Test, Inc. - 10% Owner | Open-market purchase | Common Stock, par value $0.01 per share | 29,476 | - | - | |
| Taiwan Carbon Nano Technology Corp - 10% Owner | Open-market sale | Common Stock | 29,476 | - | - | |
| Chun-Hsien Tsai - Officer | Grant or award | Common Stock | 900,000 | $2.40 | $433K | |
| Chun-Hsien Tsai - Officer | Grant or award | RSU | 900,000 | - | - | |
| Chun-Hsien Tsai - Officer | Other | RSU | 900,000 | - | - | |
| Ting-Chuan Lee - Director | Grant or award | Common Stock | 900,000 | $2.40 | $433K | |
| Ting-Chuan Lee - Director | Grant or award | RSU | 900,000 | - | - | |
| Ting-Chuan Lee - Director | Other | RSU | 900,000 | - | - | |
| Chun-Jung Tsai - Director | Grant or award | Common Stock | 900,000 | $2.40 | $433K | |
| Chun-Jung Tsai - Director | Grant or award | RSU | 900,000 | - | - | |
| Chun-Jung Tsai - Director | Other | RSU | 900,000 | - | - | |
| Hsin-Liang Christopher Lee - Officer | Grant or award | Common Stock | 19,019 | $2.30 | $9K | |
| Hsin-Liang Christopher Lee - Officer | Grant or award | Common Stock | 4,000 | $2.30 | $2K | |
| Hsin-Liang Christopher Lee - Officer | Other | RSU | 19,019 | - | - | |
| Hsin-Liang Christopher Lee - Officer | Grant or award | RSU | 4,000 | - | - | |
| Hsin-Liang Christopher Lee - Officer | Other | RSU | 4,000 | - | - | |
| Chun-Hsien Tsai - Officer | Grant or award | Common Stock | 225,032 | $2.30 | $104K | |
| Chun-Hsien Tsai - Officer | Grant or award | Common Stock | 4,000 | $2.30 | $2K | |
| Chun-Hsien Tsai - Officer | Other | RSU | 225,032 | - | - | |
| Chun-Hsien Tsai - Officer | Grant or award | RSU | 4,000 | - | - | |
| Chun-Hsien Tsai - Officer | Other | RSU | 4,000 | - | - | |
| Chun-Jung Tsai - Director | Grant or award | Common Stock | 208,797 | $2.30 | $96K | |
| Chun-Jung Tsai - Director | Grant or award | Common Stock | 4,000 | $2.30 | $2K | |
| Chun-Jung Tsai - Director | Other | RSU | 208,797 | - | - | |
| Chun-Jung Tsai - Director | Grant or award | RSU | 4,000 | - | - | |
| Chun-Jung Tsai - Director | Other | RSU | 4,000 | - | - | |
| Ting-Chuan Lee - Director | Grant or award | Common Stock | 204,721 | $2.30 | $94K | |
| Ting-Chuan Lee - Director | Grant or award | Common Stock | 4,000 | $2.30 | $2K | |
| Ting-Chuan Lee - Director | Other | RSU | 204,721 | - | - | |
| Ting-Chuan Lee - Director | Grant or award | RSU | 4,000 | - | - | |
| Ting-Chuan Lee - Director | Other | RSU | 4,000 | - | - | |
| Chun-Jung Tsai - Director | Grant or award | Common Stock | 4,200 | $2.20 | $2K | |
| Chun-Jung Tsai - Director | Other | RSU | 4,200 | - | - | |
| Ting-Chuan Lee - Director | Grant or award | Common Stock | 4,200 | $2.20 | $2K | |
| Ting-Chuan Lee - Director | Other | RSU | 4,200 | - | - | |
| Chun-Hsien Tsai - Officer | Grant or award | Common Stock | 3,000 | $2.20 | $1K | |
| Chun-Hsien Tsai - Officer | Other | RSU | 3,000 | - | - |
This is as far as the anonymous view goes. Create a free account for all 45 AIMD filings on record.
Ainos, Inc. (AIMD) had 2 insider filings in the last 90 days, with the most recent on 2026-06-09. The full record for AIMD runs to 45 Form 4 filings, the earliest from 2024-11-15. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
2 insider purchases of AIMD were filed in the last 90 days, totaling $11K.
No insider sales of AIMD were filed in the last 90 days. 24 sales are on record for this company.
This page tracks AIMD Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add AIMD to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.